Splenic ellipsoids: An early target for deposition of AA amyloid induced in mink

Amyloid

Volumn 10, Issue 4, 2003, Pages 240-249

  Wien, Tale N ^a   Sørby, Randi ^b   Espenes, Arild ^b   Gunnes, Gjermund ^b   Nordstoga, Knut ^b   Landsverk, Thor ^b   Husby, Gunnar ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

AA amyloidosis; Apolipoprotein A1; Ellipsoids; Glycosaminoglycans; Immunohistochemistry; Mink; Serum amyloid P component; Spleen

Indexed keywords

AMYLOID; AMYLOID A PROTEIN; AMYLOID P COMPONENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; GLYCOSAMINOGLYCAN; HIGH DENSITY LIPOPROTEIN; SERUM AMYLOID P;

AMYLOIDOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MINK; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SPLEEN CELL; TARGET CELL;

EID: 1642463008     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506120309041741     Document Type: Article

References (55)

1. Wien TN, Landsverk T, Espenes A, Gunnes G, Nordstoga K, and Husby G (1998). Splenic deposition of AA amyloid may be enhanced by Apo A in ellipsoids. In Kyle RA and Gertz MA (eds.) Amyloid and Amyloidosis, pp.372-374. (New York: Parthenon Publishing)
2. Schweigger-Seidel F (1863). Untersuchungen über die Milz. Virchow Archiv [Pathol Anat] 27, 460-504
3. Blue J and Weiss L (1981). Periarterial macrophage sheaths (ellipsoids) in cat spleen - an electron microscope study. Am J Anat 161, 115-134
4. Snook T (1950). A comparative study of the vascular arrangements in mammalian spleens. Am J Anat 87, 31-77
5. Dustin P (1975). Ultrastructure and function of the ellipsoids of the spleen. Their relationship with fat metabolism and red blood cells. Haematologica 60, 136-155
6. Buyssens N, Paulus G, and Bourgeois N (1984). Ellipsoids in the human spleen. Virchows Arch A Pathol Anat Histopathol 403, 27-40
7. Nossal GJ, Austin CM, Pye J, and Mitchell J (1966). Antigens in immunity. XII. Antigen trapping in the spleen. Int Arch Allergy Appl Immunol 29, 368-383
8. Dustin P (1971). The ellipsoids (sheaths of Schweigger-Seidel) of the human spleen in various pathological conditions. J Pathol 104, ii
9. Husby G (1992). Amyloidosis. Semin Arthritis Rheum 22, 67-82
10. Kisilevsky R and Boudreau L (1983). Kinetics of amyloid deposition. I. The effects of amyloid-enhancing factor and splenectomy. Lab Invest 48, 53-59
11. Wien TN, Omtvedt LA, Landsverk T, and Husby G (2000). Characterization of proteoglycans and glycosaminoglycans in splenic AA amyloid induced in mink. Scand J Immunol 52, 576-583
12. Puchtler H, Sweat F, and Levine M (1962). On the binding of Congo red by amyloid. J Histochem Cytochem 10, 355-364
13. Askanas V, Engel WK, and Alvarez RB (1993). Enhanced detection of congo-red-positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer's disease using fluorescence technique. Neurology 43, 1265-1267
14. Linke RP (2000). Highly sensitive diagnosis of amyloid and various amyloid syndromes using Congo red fluorescence. Virchows Arch 436, 439-448
15. Shively JE and Conrad HE (1976). Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry 15, 3932-3942
16. Snow AD, Kisilevsky R, Stephens C, and Anastassiades T (1987). Characterization of tissue and plasma glycosaminoglycans during experimental AA amyloidosis and acute inflammation. Qualitative and quantitative analysis. Lab Invest 56, 665-675
17. Saito H, Yamagata T, and Suzuki S (1968). Enzymatic methods for the determination of small quantities of isomeric chondroitin sulfates. J Biol Chem 243, 1536-1542
18. Scott JE and Dorling J (1965). Differential staining of acid glycosaminoglycans (mucopolysaccharides) by alcian blue in salt solutions. Histochemie 5, 221-233
19. Mowry RW and Scott JE (1967). Observations on the basophilia of amyloids. Histochemie 10, 8-32
20. Bruun CF, Rygg M, Nordstoga K, Sletten K, and Marhaug G (1994). Serum amyloid A protein in mink during endotoxin induced inflammation and amyloidogenesis. Scand J Immunol 40, 337-344
21. Towbin H, Staehelin T, and Gordon J (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76, 4350-4354
22. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685
23. Zschiesche W and Jakob W (1989). Pathology of animal amyloidoses. Pharmacol Ther 41, 49-83
24. Nordstoga K (1973). The effect of long-term challenge with endotoxin on infectious mink plasmacytosis. Acta Pathol Microbiol Scand [A] 81, 347-351
25. Nordstoga K (1972). Amyloidosis in mink induced by repeated injections of endotoxin. Acta Pathol Microbiol Scand [A] 80, 159-168
26. Kisilevsky R (2000). The relation of proteoglycans, serum amyloid P and apo E to amyloidosis current status, 2000. Amyloid Int J Exp Clin Invest 7, 23-25
27. Pepys MB, Booth DR, Hutchinson WL, Gallimore JR, Collins PM, and Hohenester E (1997). Amyloid P Component. A critical review. Amyloid Int J Exp Clin Invest 4, 274-295
28. Gallo G, Wisniewski T, Choi-Miura NH, Ghiso J, and Frangione B (1994). Potential role of apolipoprotein-E in fibrillogenesis. Am J Pathol 145, 526-530
29. Wisniewski T and Frangione B (1992). Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 135, 235-238
30. White RG, Henderson DC, Eslami MB, and Neilsen KH (1975). Localization of aprotein antigen in the chicken spleen. Effect of various manipulative procedures on the morphogenesis of the germinal centre. Immunology 28, 1-21
31. Espenes A, Press CM, Dannevig BH, and Landsverk T (1995). Investigation of the structural and functional features of splenic ellipsoids in rainbow trout (Oncorhynchus mykiss). Cell Tissue Res 279, 469-474
32. Hardt F and Ranlov P (1968). Transfer amyloidosis. Local and systemic amyloidosis in recipients of syngeneic spleen grafts from non-amyloidotic, casein-sensitized donor mice. Acta Pathol Microbiol Scand 73, 549-558
33. Hardt F and Ranlov P (1976). Transfer amyloidosis. Int Rev Exp Pathol 16, 273-334
34. Axelrad MA, Kisilevsky R, Willmer J, Chen SJ, and Skinner M (1982). Further characterization of amyloid-enhancing factor. Lab Invest 47, 139-146
35. Cabana VG, Lukens JR, Rice KS, Hawkins TJ, and Getz GS (1996). HDL content and composition in acute phase response in three species: triglyceride enrichment of HDL a factor in its decrease. J Lipid Res 37, 2662-2674
36. Marcovina SM, Gaur VP, and Albers JJ (1994). Biological variability of cholesterol, triglyceride, low-and high-density lipoprotein cholesterol, lipoprotein(a), and apolipoproteins A-I and B. Clin Chem 40, 574-578
37. Husebekk A, Skogen B, and Husby G (1987). Characterization of amyloid proteins AA and SAA as apolipoproteins of high density lipoprotein (HDL). Displacement of SAA from the HDL-SAA complex by apo AI and apo AII. Scand J Immunol 25, 375-381
38. Glass CK, Pittman RC, Keller GA, and Steinberg D (1983). Tissue sites of degradation of apoprotein A-I in the rat. J Biol Chem 258, 7161-7167
39. Husby G, Marhaug G, Dowton B, Sletten K, and Sipe JD (1994). Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid 1, 119-137
40. Yamada T, Wada A, Fukuda T, Itoh Y, and Itoh K (1999). Changes in plasma apolipoprotein AI and AII concentrations in murine reactive amyloidosis. Scand J Immunol 50, 475-478
41. Wisniewski T, Golabek AA, Kida E, Wisniewski KE, and Frangione B (1995). Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis. Am J Pathol 147, 238-244
42. Harr SD, Uint L, Hollister R, Hyman BT, and Mendez AJ (1996). Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease. J Neurochem 66, 2429-2435
43. Bergström J, Murphy C, Eulitz M, Weiss DT, Westermark GT, Solomon A, and Westermark P (2001). Codeposition of apolipoprotein A-IV and transthyretin in senile systemic (ATTR) amyloidosis. Biochem Biophys Res Commun 285, 903-908
44. Husby G, Natvig JB, Sletten K, Nordstoga K, and Anders RF (1975). An experimental model in mink for studying the relation between amyloid fibril protein AA and the related serum protein SAA. Scand J Immunol 4, 811-816
45. Waalen K, Sletten K, Husby G, and Nordstoga K (1980). The primary structure of amyloid fibril protein AA in endotoxin-induced amyloidosis of the mink. Eur J Biochem 104, 407-412
46. Westermark P, Mucchiano G, Marthin T, Johnson KH, and Sletten K (1995). Apolipoprotein A1-derived amyloid in human aortic atherosclerotic plaques. Am J Pathol 147, 1186-1192
47. Mucchiano GI, Haggqvist B, Sletten K, and Westermark P (2001). Apolipoprotein A-1-derived amyloid in atherosclerotic plaques of the human aorta. J Pathol 193, 270-275
48. Roertgen KE, Lund EM, O'Brien TD, Westermark P, Hayden DW, and Johnson KH (1995). Apolipoprotein AI-derived pulmonary vascular amyloid in aged dogs. Am J Pathol 147, 1311-1317
49. Sorci-Thomas MG and Thomas MJ (2002). The effects of altered apolipoprotein A-I structure on plasma HDL concentration. Trends Cardiovasc Med 12, 121-128
50. Baltz ML, Caspi D, Evans DJ, Rowe IF, Hind CR, and Pepys MB (1986). Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits. Clin Exp Immunol 66, 691-700
51. Dyck RF, Lockwood CM, Kershaw M, McHugh N, Duance VC, Baltz ML, and Pepys MB (1980). Amyloid P-component is a constituent of normal human glomerular basement membrane. J Exp Med 152, 1162-1174
52. al-Mutlaq H, Wheeler J, Robertson H, Watchorn C, and Morley AR (1993). Tissue distribution of amyloid P component as defined by a monoclonal antibody produced by immunization with human glomerular basement membranes. Histochem J 25, 219-227
53. Inoue S and Kisilevsky R (1996). A high resolution ultrastructural study of experimental murine AA amyloid. Lab Invest 74, 670-683
54. Inoue S, Kuroiwa M, and Kisilevsky R (2002). AA protein in experimental murine AA amyloid fibrils: A high resolution ultrastructural and immunohistochemical study comparing aldehyde-fixed and cryofixed tissues. Amyloid Int J Exp Clin Invest 9, 115-125
55. Magnus JH and Stenstad T (1997). Proteoglycans and the extracellular matrix in amyloidosis. Amyloid J Protein Folding Dis 4, 121-134